Marqibo Patient assistance program
Complete a free online enrollment application to find out if you’re eligible to pay only $49 per month for your Marqibo medication with our help.Get started today
- Secure: Your personal and medical information is safe with us
- Convenient: We manage the whole process and we’re here to assist you
- Ongoing refills: We request your medication refills on your behalf
NiceRx works with your healthcare provider to help you access affordable medications directly from U.S. pharmaceutical companies.
An introduction to NiceRx(01:52)
Next steps after qualifying(00:38)
Uploading documents and billing(00:50)
SSN & billing information(00:33)
Medication delivery time(00:41)
How it works
Get started by filling out the online enrollment application to find out if you are eligible.
NiceRx verifies your eligibility for medication assistance and notifies you if you are qualified. The pharmaceutical company provides your medication for free and you only pay our service fee.
You may be required to submit further information and documents required by the pharmaceutical company which can be securely uploaded online.
Your application is created and sent to your doctor for signature. At this stage, you will be billed $49 and will not be billed again until you receive your first medication delivery.
Your application is sent to the pharmaceutical company. You will be billed again once you receive your medication. We handle the entire ordering process including requesting ongoing refills.
Your monthly Marqibo cost savings if eligible
With our assistance, you could access the Marqibo patient assistance program and obtain your medication for free. We only charge a flat monthly fee of $49 per medication for our services.
Am I eligible for Marqibo patient assistance?
We review each Marqibo enrollment application individually to determine if you are eligible. Each assistance program has its own eligibility criteria and the factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Marqibo patient assistance program?
Our process makes it as easy as possible to apply for the Marqibo patient assistance program. Begin by completing the enrollment application form on our website. Tell us about any medications that you are taking, including Marqibo, your healthcare provider, your insurance plan, and your household income. This information is required by the pharmaceutical manufacturers who will supply the medication, so it is important to make sure this information is accurate and up to date.
We will review the information that you have provided to determine whether you are eligible for patient assistance. If we can pre-qualify you for assistance, NiceRx will handle the full enrollment process on your behalf. If you are approved by the pharmaceutical company, you will typically start receiving your medication in 6 – 8 weeks.
Is NiceRx a Marqibo coupon provider?
NiceRx is not a Marqibo coupon, Marqibo discount card, or Marqibo copay card provider. We do not offer Marqibo manufacturer coupons, Marqibo discounts, rebates, Marqibo savings cards, trial offers, or free Marqibo samples. We are a service provider that helps eligible individuals access their medication directly from the U.S. pharmaceutical company.
Can NiceRx help me get Marqibo cheaper if I have insurance?
NiceRx may be able to help you if:
- You have a high copay or coinsurance responsibility for Marqibo
- Your insurance company will not pay for your Marqibo prescription
- Your healthcare plan does not cover your medication
- You do not have insurance
Please apply online to find out if we can help you.
How much does Marqibo cost without insurance?
Without insurance, Marqibo costs will vary depending on where you buy the medication as prices will vary by retailer. As a guide, Marqibo intravenous kit (5 mg/31 mL) will cost around $18,100 for 1 kit.
How much does Marqibo cost with insurance?
The copay for Marqibo will depend on the terms of your healthcare plan. Your healthcare provider or pharmacist will be able to calculate your copay with your current insurance. Contact them to find out more.
What is Marqibo?
Marqibo is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Acrotech Biopharma LLC. Marqibo is a cancer medication that interferes with the growth of cancer cells and slows their spread in the body. It is classed as a vinca alkaloid indicated for the treatment of adult patients with Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL) in second or greater relapse or whose disease has progressed following two or more anti-leukemia therapies. This indication is based on the overall response rate.
Marqibo has also been shown to be useful in combination with other oncolytic agents in Hodgkin’s disease, non-Hodgkin’s malignant lymphomas, rhabdomyosarcoma, neuroblastoma, and Wilms’ tumor.
What doses of Marqibo are available?
Marqibo is prepared on-site from the components in the Kit. After preparation, each single-dose vial of Marqibo (vinCRIStine sulfate LIPOSOME injection) contains 5 mg/31 mL (0.16 mg/mL) vincristine sulfate.
Marqibo is for intravenous use only. Do not administer by any other route. Administer Marqibo at a dose of 2.25 mg/m2 intravenously over 1 hour once every 7 days.
Marqibo (vinCRIStine sulfate LIPOSOME injection) has different dosage recommendations than vinCRIStine sulfate injection. Verify the drug name and dose prior to preparation and administration to avoid overdosage.
Please see the full prescribing information and always speak with a healthcare professional for medical advice about any changes to your dose so they can monitor and evaluate your condition.
Marqibo active ingredients
The active ingredient of Marqibo is a sphingomyelin/cholesterol liposome-encapsulated formulation of vincristine sulfate. Non-liposomal vincristine sulfate binds to tubulin, altering the tubulin polymerization equilibrium, resulting in altered microtubule structure and function. Non-liposomal vincristine sulfate stabilizes the spindle apparatus, preventing chromosome segregation, triggering metaphase arrest and inhibiting of mitosis.
Marqibo side effects
The most common side effects of Marqibo in clinical trials (incidence ≥ 30%) include:
- Constipation, diarrhea
- Decreased appetite
- Peripheral neuropathy
- Febrile neutropenia
In rare instances, Marqibo can cause more serious side effects. These can include:
- Intrathecal administration is fatal
- Neurologic toxicity
- Myelosuppression – monitor blood counts prior to each dose
- Neutropenia, thrombocytopenia, or anemia
- Tumor lysis syndrome
- Constipation, bowel obstruction, and/or paralytic ileus
- Severe fatigue
- Hepatic toxicity
- Embryo-fetal toxicity
Your doctor will assess the benefits of using Marqibo against your risk of adverse events. Patients are encouraged to report negative side effects or adverse reactions of Marqibo to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Marqibo drug interactions
Marqibo can interact with other medications. These include:
- Strong CYP3A inhibitors
- Strong CYP3A inducers
- P-Glycoprotein inhibitors and inducers
This list is not exhaustive and other prescription drugs may interact with Marqibo.
You should not use Marqibo if you:
- Are allergic to the active ingredient vinCRIStine sulfate LIPOSOME injection
- Are allergic to any of the other ingredients in Marqibo
- Have Charcot-Marie-Tooth syndrome or other conditions that cause damage to myelin (protective covering of the nerves in your brain and spinal cord)
- Are pregnant or are planning to become pregnant – females of reproductive potential are advised to use effective contraception during treatment and for 6 months after the last dose
Talk to your doctor before using Marqibo if you:
- Are taking any of the medications that could interact with Marqibo
- Have liver disease
- Have myasthenia gravis, ALS (Lou Gehrig’s disease), multiple sclerosis, or muscular dystrophy
- Have a bowel obstruction called paralytic ileus
- Have peripheral vascular disease such as Raynaud’s syndrome
- Are breastfeeding or are planning to breastfeed
Marqibo is the trademark brand name for vinCRIStine sulfate LIPOSOME injection manufactured by Acrotech Biopharma LLC. A generic version of vinCRIStine sulfate LIPOSOME injection is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Marqibo savings through NiceRx.
*Qualifying persons may obtain medications directly from patient assistance programs without any out-of-pocket cost (or for less than $49 per medication). However, our monthly flat rate of just $49 per medication spares you the hassle of tracking down the different programs and filling out all the required paperwork for each program.
Enrollees enjoy a full-service solution, as NiceRx assists them and their physicians with the entire process. We prepare all required documents for the physician to sign, help enrollees manage all prescription refills, monitor eligibility criteria, and maintain enrollment.
**If you do not receive medications because you were determined to be ineligible for the prescription assistance by the applicable pharmaceutical companies and you have a letter of denial, we will refund any fees you paid toward medications for which you did not qualify to receive prescription assistance (“Refund”).
To receive a refund, you must send the letter of denial to us by fax to 888-517-7444, or by e-mail to [email protected] within 30 days of your receipt of such letter. The Refund is your sole and exclusive remedy for any fees you may wish to dispute.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.